Abaloparatide Peptide

High Standards·Traceability·Scalability

Please feel free to contact Xi'an Sonwu Biotech Co., Ltd. for any products you are interested in.

Send Inquiry Now

Abaloparatide peptide is a parathyroid hormone-related peptide (PTHrP) analog primarily used to improve bone mineral density in patients with osteoporosis. It works by mimicking the effects of parathyroid hormone, enhancing bone formation and increasing bone density and strength. After binding to the PTH1 receptor, it promotes bone formation, mainly by stimulating osteoblast activity, thereby accelerating new bone formation, reducing bone resorption, and ultimately strengthening bone mass. Unlike traditional osteoporosis medications, it plays a crucial role in promoting bone formation, rather than simply inhibiting bone resorption. This unique mechanism helps maintain better bone structure, increases bone density, and reduces the risk of fractures. Furthermore, activating specific receptors in bone, it promotes new bone formation, further enhancing bone quality and making the patient's bones more stable, reducing injuries caused by bone fragility. If you are interested in Abaloparatide powder suppliers, you can contact Xi'an Sonwu Biotech Co., Ltd.

Xi'an Sonwu Biotech Co., Ltd is a peptide raw material supplier with peptide technology at its core and an international market orientation. Sonwu specializes in the R&D, production, and global supply of functional peptides and polypeptide raw materials. Sonwu's products are widely applied in multiple fields, including muscle building, beauty and anti-aging, hair health, weight management, nootropics, and pharmaceutical raw materials.

Sonwu's products have been widely used in customers' R&D and industrialization projects worldwide. Based on this, Sonwu has received a lot of feedback on Sonwu's products. Therefore, if you need Abaloparatide powder, please contact Xi'an Sonwu.

Xi'an Sonwu not only provides large-scale production services but can also provide sample packages to customers first.

Xi'an Sonwu not only supplies high-quality Abaloparatide peptide but also offers customised products according to customer needs.

Firstly, for customised products, customers need to provide information such as the product's CAS number and synthesis route. Sonwu will help you verify whether customisation is possible based on your requirements, or Sonwu will provide professional suggestions.

Secondly, regarding customised packaging, Sonwu's products are available in minimum packaging sizes of 1g, and Sonwu can also provide customised packaging upon customer request.

1. Osteogenic Activity
It promotes the formation of new bone by activating PTH1 receptors (PTH1R) located on osteoblasts (bone-forming cells). This mechanism of action distinguishes it from other common osteoporosis treatments; it primarily enhances bone formation rather than inhibiting bone resorption. By stimulating PTH1R, it effectively increases osteoblast activity, accelerates bone formation, and facilitates bone repair and regeneration. Its use provides enhanced skeletal structural support, thereby mitigating the risk of fractures associated with declining bone density. Furthermore, the osteogenic activity of this peptide makes it particularly effective for bones compromised by osteoporosis, improving skeletal health and providing robust structural support to the bone framework.
2. Reducing Fracture Risk

It is widely utilized to manage osteoporosis, particularly in postmenopausal women facing a high risk of fractures. It effectively reduces the risk of fractures by stimulating bone formation and inhibiting bone resorption. As bone mineral density increases, skeletal strength improves, reducing the patient's risk of fracture. It demonstrates particularly notable efficacy in patients who have previously sustained fractures or for whom other treatment regimens have proven ineffective. By slowing bone resorption and promoting new bone formation, the medication strengthens the skeleton, providing superior protection against injury-even during activities that involve significant physical stress. In summary, it employs a comprehensive approach to mitigate the risk of fractures-including those affecting the spine and other skeletal sites-thereby helping patients avoid the debilitating consequences of osteoporosis-related bone fractures.

3. Increasing Bone Density

It has demonstrated significant efficacy in increasing bone density, with particularly pronounced effects observed in the lumbar spine, femoral neck, and hip regions. By stimulating the formation of new bone tissue, it effectively boosts bone density in these specific areas, thereby enhancing overall skeletal strength and stability. This increase in bone density not only helps mitigate the risk of fractures but also, to a certain extent, improves patients' quality of life. The increase in hip bone density, in particular, confers a distinct advantage in the treatment of osteoporosis. Compared with similar medications-such as teriparatide-it exhibits superior efficacy in increasing bone density in the hip; consequently, it provides patients with osteoporosis with stronger skeletal support, facilitating their return to normal daily functioning and further reducing the likelihood of fractures.

1. Selective Receptor Agonist Action

As a selective receptor agonist, it exerts its effects by binding to the RG conformation of the PTH1R receptor, rather than the R0 conformation targeted by teriparatide. Compared to other similar drugs, this selective binding allows it to trigger a shorter signal transduction pathway and reduce osteoclast stimulation when activating osteoblasts. This mechanism enables it to promote bone formation while stimulating bone resorption to a lesser extent, thereby minimizing adverse side effects while increasing bone density and strength. This selective action not only improves therapeutic efficacy but also reduces the drug's negative impact on bones, helping to prevent problems such as hypercalcemia that may occur in patients with osteoporosis during treatment.

2. Bone Formation Effect (Promoting Bone Formation)

It significantly enhances bone formation by stimulating the Gs protein-mediated cyclic adenosine monophosphate (cAMP) pathway. This mechanism promotes osteoblast proliferation and differentiation, increasing bone surface formation, particularly in trabecular bone, the inner periosteum, and the outer periosteum. cAMP, a key signaling molecule, activates multiple molecular pathways related to bone formation, thereby promoting new bone formation. In this way, it effectively increases bone mineral density and strengthens bones, significantly reducing the risk of fractures. Unlike other osteoporosis drugs, this peptide's effect makes it a treatment option for long-term improvement in bone health, helping patients restore normal bone function and avoid fractures.

3. Osteoblast Activity

It enhances osteoblast proliferation and bone formation while inhibiting osteoblast apoptosis, thereby increasing bone density and strength. It promotes bone matrix synthesis and improves bone formation efficiency by activating osteoblast function. This mechanism plays a crucial role in osteoporosis treatment, especially for individuals who have experienced fractures or significant bone density loss, effectively enhancing bone strength. Promoting osteoblast proliferation and reducing apoptosis, it helps restore bones to a healthy state, enhancing bone resilience and stress resistance. Furthermore, its supportive effect on bones extends beyond increased bone density to promote long-term bone health, helping prevent future fractures.

Xi'an Sonwu Biotech Co., Ltd. has established a complete technology platform covering peptide molecular design, custom synthesis, precision purification, structural identification, and quality control. Strictly adhering to international quality management standards, the company ensures its peptide raw materials meet the high-end raw material requirements of overseas customers for purity, stability, and batch consistency.

Looking to the future, Sonwu will continue to deepen peptide technology innovation, expand Sonwu's global cooperation network, and strive to become a trusted, long-term peptide raw material solution partner for international customers.

CERES

HACCP

HALAL

ISO9001

ISO14001

ISO22000

 

In addition to ensuring product quality, another critical priority is guaranteeing smooth delivery for Sonwu's clients. Therefore, Xi'an Sonwu offers a variety of courier options tailored to diverse needs.

1. What is the difference between Abaloparatide and Teriparatide?

Both teriparatide and Abaloparatide are bone-regeneration drugs, but Abaloparatide selectively activates the RG conformation of the PTH1R receptor, leading to lower bone-resorption stimulation and fewer side effects.

2. Can it reduce the risk of fractures?

Yes, it can significantly reduce the risk of spinal and non-spinal fractures by increasing bone density and strength.

3. What is the mechanism of action of it?

It promotes osteoblast proliferation and bone formation by selectively activating the RG conformation of the PTH1R receptor, while reducing bone resorption, thereby enhancing bone density and strength.

If you are looking for an Abaloparatide powder supplier, contact Xi'an Sonwu. Click the email, and then you get high-quality Abaloparatide peptide.

Email: sales02@sonwu.com

Hot Tags: abaloparatide peptide, China abaloparatide peptide manufacturers, suppliers, factory, pharmaceutical peptides, Piperlongumine Powder, TB500 Powder